✦ LIBER ✦

2-31-25 Development of neutralizing antibodies in patients treated with IFN beta 1a

✍ Scribed by C. Pozzili; G. Antonelli; F. Bagnato; E. Simeoni; S. Galgani; C. Gasperini; T. Koudriatseva; M. Salvetti; S. Bastianello; C. Fieschi; F. Dianzani

Book ID: 119469492
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 175 KB
Volume: 150
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(97)85438-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of neutralizing antibodies ag

Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients

✍ Andrew R. Pachner; Jennifer Brady; Israel Steiner; Kavitha Narayan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 124 KB

Fate of neutralizing and binding antibod

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

✍ Francesca Bellomi; Carolina Scagnolari; Valentina Tomassini; Claudio Gasperini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Further study on the specificity and inc

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Neutralizing antibodies against IFN beta

Neutralizing antibodies against IFN beta in patients with multiple sclerosis: A comparative study of two cytopathic effect tests (CPE) for their detection

✍ B. Oliver; T. Órpez; C. Mayorga; M.J. Pinto-Medel; L. Leyva; C. López-Gómez; C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

OPL098 To evaluate anti-interferon (IFN)

OPL098 To evaluate anti-interferon (IFN) neutralizing antibody (NAb) in relapsing remitting (RR) MS patients treated over the long term with an IFN beta-1b dose higher than that currently approved

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Development and specificities of anti-in

Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α

✍ C. Scagnolari; S. Trombetti; A. Soldà; M. Milella; G. B. Gaeta; G. Angarano; G. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB